Kymera Therapeutics, Inc.
KYMR
$81.21
$1.612.02%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 67.75% | -24.01% | 43.68% | -5.24% | -11.13% |
| Total Receivables | -- | -- | 100.00% | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.42% | -1.16% | 28.54% | -17.30% | 23.50% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 64.91% | -27.46% | 45.39% | -1.83% | -10.28% |
|
|
|||||
| Total Current Assets | 64.91% | -27.46% | 45.39% | -1.83% | -10.28% |
| Net Property, Plant & Equipment | -2.89% | -6.91% | -1.34% | -2.00% | -1.46% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 18.21% | 20.21% | 15.08% | 17.77% | 33.91% |
| Total Assets | 58.14% | -2.57% | 23.17% | -6.11% | -5.49% |
|
|
|||||
| Total Accounts Payable | -27.08% | -4.76% | -43.67% | 71.36% | -7.78% |
| Total Accrued Expenses | 47.61% | 2.37% | 21.02% | -33.70% | 31.42% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.09% | 0.56% | 3.22% | 0.98% | 2.03% |
| Total Finance Division Other Current Liabilities | -2.20% | -40.96% | 224.34% | -10.36% | -33.20% |
| Total Other Current Liabilities | -2.20% | -40.96% | 224.34% | -10.36% | -33.20% |
| Total Current Liabilities | 16.26% | -18.24% | 48.40% | -12.95% | 1.86% |
|
|
|||||
| Total Current Liabilities | 16.26% | -18.24% | 48.40% | -12.95% | 1.86% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -2.50% | -2.49% | -1.43% | -2.09% | -0.97% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -18.03% | -- | -- | -- | -- |
| Total Liabilities | 4.73% | -2.38% | 20.83% | -7.26% | 0.36% |
|
|
|||||
| Common Stock & APIC | 37.43% | 2.98% | 16.28% | 0.93% | 1.07% |
| Retained Earnings | -8.88% | -9.16% | -9.34% | -8.69% | -10.35% |
| Treasury Stock & Other | 19.92% | 437.99% | 581.03% | 96.09% | -176.90% |
| Total Common Equity | 66.94% | -2.60% | 23.56% | -5.91% | -6.42% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 66.94% | -2.60% | 23.56% | -5.91% | -6.42% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 66.94% | -2.60% | 23.56% | -5.91% | -6.42% |
|
|
|||||